Vinod H. Srihari, MD, professor of psychiatry, has been awarded the 2025 Outstanding Clinical and Community Research Award by the Schizophrenia International Research Society (SIRS).
Established in 2012, the award recognizes a member for an outstanding clinical and community contribution to schizophrenia research and may be based on a single discovery or cumulative body of work.
Srihari is director of the Program for Specialized Treatment Early in Psychosis (STEP) at Yale. STEP, which originated at the Connecticut Mental Health Center, completed the first U.S. randomized trial demonstrating the effectiveness, and cost-benefits of a specialty team-based model of care, subsequently termed Coordinated Specialty Care (CSC) by the NIMH. STEP also completed the first U.S. test of an early detection campaign that was able to reduce the median duration of untreated psychosis from 10 to five months in the Greater New Haven area.
This comprehensive early intervention service is now the hub for a statewide learning health system that leverages a network of clinics to provide rapid access to high quality care for all individuals with recent onset schizophrenia spectrum disorders, and to facilitate research to develop improved interventions.
Learn more about Srihari and the SIRS 2025 Outstanding Clinical and Community Research Award.